ICD-10 Code C92.11 | Chronic myeloid leukemia, BCR/ABL-positive, in remission Symptoms, Diagnosis, Billing

Chronic myeloid leukemia (CML) is a hematological malignancy characterized by the overproduction of myeloid cells in the bone marrow, often associated with the BCR-ABL fusion gene. The remission phase indicates a significant reduction in disease activity, which is clinically important for treatment planning and monitoring. ICD-10 Code C92.11 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring appropriate care and resource allocation.

What is ICD-10 Code C92.11 for Chronic myeloid leukemia, BCR/ABL-positive, in remission?

ICD-10 Code C92.11 represents Chronic myeloid leukemia, BCR/ABL-positive, in remission. This code is used when a patient has achieved remission from CML, characterized by the absence of symptoms and a significant decrease in leukemic cells. It is essential for clinical documentation and billing to reflect the patient's current health status accurately.

ICD-10 Code C92.11 – Clinical Definition and Explanation of Chronic myeloid leukemia, BCR/ABL-positive, in remission

Chronic myeloid leukemia, BCR/ABL-positive, in remission is caused by a genetic mutation leading to the production of the BCR-ABL fusion protein, which promotes uncontrolled cell division. The disease progresses through phases, and remission indicates a favorable response to treatment, necessitating ongoing medical supervision.

Key Clinical Features:

• Presence of the BCR-ABL fusion gene detected via molecular testing.
• Symptoms may include fatigue, splenomegaly, and leukocytosis during active disease.
• Remission is defined by normal blood counts and absence of disease symptoms.
• Regular monitoring is essential to detect potential relapse.

ICD-10 Code C92.11 for Chronic myeloid leukemia, BCR/ABL-positive, in remission – SOAP Notes & Clinical Use

ICD-10 Code C92.11 is utilized in SOAP notes to document the patient's remission status, guiding treatment decisions and follow-up care. It plays a crucial role in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code C92.11 for Chronic myeloid leukemia, BCR/ABL-positive, in remission Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C92.11 connects subjective patient reports and objective clinical findings to a formal diagnosis of remission in CML. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code C92.11 – Chronic myeloid leukemia, BCR/ABL-positive, in remission

Management of Chronic myeloid leukemia, BCR/ABL-positive, in remission focuses on maintaining remission and monitoring for relapse.

Antibiotic Therapy:

• Not applicable as CML is not an infectious disease.

Supportive Care:

• Regular follow-up appointments for blood tests and monitoring.
• Patient education on signs of relapse and when to seek care.
• Psychosocial support to address emotional and psychological needs.

Infection Control:

• Standard precautions to prevent infections during treatment.
• Vaccinations as appropriate, following guidelines.

How to Document Symptoms of Chronic myeloid leukemia, BCR/ABL-positive, in remission (ICD-10 C92.11) in SOAP Notes

Subjective:

• Patient reports feeling well with no current symptoms.
• No fatigue, fever, or night sweats noted.
• Denies any new lumps or swelling.

Objective:

• Complete blood count shows normal white blood cell count.
• Physical examination reveals no splenomegaly or lymphadenopathy.
• Molecular testing confirms absence of BCR-ABL transcripts.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Chronic myeloid leukemia, BCR/ABL-positive, in remission (ICD-10 Code C92.11)

Assessment:

• Chronic myeloid leukemia, BCR/ABL-positive, in remission (ICD-10 C92.11).
• Patient is stable with no evidence of disease activity.
• Regular monitoring is essential to prevent relapse.

Plan:

• Continue current treatment regimen as per oncologist's recommendations.
• Schedule follow-up in 3 months for routine blood work.
• Educate patient on signs of potential relapse and when to seek immediate care.

Treatment & Plan Section for ICD-10 Code C92.11 – Chronic myeloid leukemia, BCR/ABL-positive, in remission

• Maintain adherence to tyrosine kinase inhibitors as prescribed.
• Encourage a healthy lifestyle, including diet and exercise.
• Regular monitoring of blood counts and molecular markers.
• Provide resources for emotional support and counseling.

Using ICD-10 Code C92.11 for Chronic myeloid leukemia, BCR/ABL-positive, in remission in Billing & SOAP Note Compliance

• Ensure accurate documentation of remission status in patient records.
• Use C92.11 in conjunction with relevant treatment codes for billing.
• Document all clinical findings clearly in Subjective (S) and Objective (O) sections.
• Align treatment plans with clinical guidelines to support justified billing.

Related ICD-10 Codes Often Used with Chronic myeloid leukemia, BCR/ABL-positive, in remission

• C92.12 – Chronic myeloid leukemia, BCR/ABL-positive, in blast phase
• C92.10 – Chronic myeloid leukemia, BCR/ABL-positive, unspecified

ICD-10 Code C92.11 in Medical Billing and Insurance for Chronic myeloid leukemia, BCR/ABL-positive, in remission

ICD-10 Code C92.11 is critical for accurate billing in hospital, ER, or outpatient settings, ensuring proper reimbursement for care provided.

Billing Notes:

• Document the patient's remission status clearly to support claims.
• Use C92.11 in conjunction with treatment codes for comprehensive billing.
• Ensure all relevant clinical information is included in the medical record.

Common CPT Pairings: